Contact
Please use this form to send email to PR contact of this press release:
Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary - Innate Immune, Inc.
TO:
Please use this form to send email to PR contact of this press release:
Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary - Innate Immune, Inc.
TO: